Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.

Surdacki A, Kruszelnicka O, Rakowski T, Jaźwińska-Kozuba A, Dubiel JS.

Cardiovasc Diabetol. 2013;12:64. doi: 10.1186/1475-2840-12-64.

PMID:
23578341
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.

Chhabra KH, Xia H, Pedersen KB, Speth RC, Lazartigues E.

Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E874-84. doi: 10.1152/ajpendo.00490.2012. Epub 2013 Mar 5.

PMID:
23462816
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The endothelium in diabetes: its role in insulin access and diabetic complications.

Kolka CM, Bergman RN.

Rev Endocr Metab Disord. 2013 Mar;14(1):13-9. doi: 10.1007/s11154-012-9233-5. Review.

PMID:
23306780
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC; Chronic Kidney Disease Prognosis Consortium.

Lancet. 2012 Nov 10;380(9854):1649-61. doi: 10.1016/S0140-6736(12)61272-0. Epub 2012 Sep 24. Review. Erratum in: Lancet. 2012 Nov 10;380(9854):1648.

PMID:
23013600
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.

van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E.

Eur Heart J. 2012 Aug;33(16):2088-97. doi: 10.1093/eurheartj/ehs075. Epub 2012 Apr 17. Review.

PMID:
22511654
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil.

Volpe M, Savoia C.

Integr Blood Press Control. 2012;5:19-25. doi: 10.2147/IBPC.S13784. Epub 2012 Mar 12.

PMID:
22457601
[PubMed]
Free PMC Article
7.

Differential pharmacology and benefit/risk of azilsartan compared to other sartans.

Kurtz TW, Kajiya T.

Vasc Health Risk Manag. 2012;8:133-43. doi: 10.2147/VHRM.S22595. Epub 2012 Feb 28. Review.

PMID:
22399858
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study.

Zidek W, Schrader J, Lüders S, Matthaei S, Hasslacher C, Hoyer J, Zemmrich C, Bramlage P, Sturm CD, Paar WD.

Cardiovasc Diabetol. 2012 Jan 9;11:1. doi: 10.1186/1475-2840-11-1.

PMID:
22230104
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

Putnam K, Shoemaker R, Yiannikouris F, Cassis LA.

Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1219-30. doi: 10.1152/ajpheart.00796.2011. Epub 2012 Jan 6. Review.

PMID:
22227126
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Potassium and risk of Type 2 diabetes.

Chatterjee R, Yeh HC, Edelman D, Brancati F.

Expert Rev Endocrinol Metab. 2011 Sep;6(5):665-672.

PMID:
22025927
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk